The Rise and Fall of Hellman Jordan Management Co Inc's 13F Holdings in Q3 2022 vs. Q4 2022

Hellman Jordan Management Co Inc is a major player in the world of asset management, and their quarterly 13F filings give us a glimpse into their investment strategies. In this article, we'll take a deep dive into their Q3 2022 holdings and compare them with their Q4 2022 holdings to identify trends and changes. We'll explore the reasoning behind any notable shifts in investments and assess the impact of those changes.

One of the most significant changes in Hellman Jordan's portfolio was their increase in holdings of the iShares Nasdaq Biotech ETF (IBB). In Q3 2022, they held 16,566 shares worth $1.94 million, but in Q4 2022, the number of shares increased to 27,197, with a value of $3.57 million - a change of 84.3%. This shift could be due to newfound optimism about the biotech industry, increased investor attention, or a belief that the ETF was previously undervalued.

Another notable change was in their holdings of Chart Industries Inc (GTLS). In Q3 2022, they held 16,702 shares worth $3.07 million, but in Q4 2022, they held only 17,820 shares, worth $2.05 million - a decrease of 33.3%. This could be due to a lack of confidence in the company's future potential or a strategic move to free up capital for other investments.

UnitedHealth Group (UNH) was another company in which Hellman Jordan increased its holdings. In Q3 2022, they held 3,825 shares worth $1.93 million, but in Q4 2022, the number of shares rose to 4,767, with a value of $2.53 million - a percentage increase of 30.8%. This could be a result of the increased demand for healthcare services, the company's solid financial performance, or a belief that the stock was undervalued.

Glancing at their holdings of the SPDR Gold Shares ETF (GLD), we can see that Hellman Jordan decreased their holdings from 20,819 shares worth $3.22 million in Q3 2022 to 13,989 shares worth $2.37 million in Q4 2022 - a drop of 26.3%. This could suggest a lack of faith in the precious metal market or a strategic move to liquidate some holdings.

Several other significant changes in Hellman Jordan's holdings include the increase in holdings of Diamondback Energy Inc (FANG), RingCentral Inc - Class A (RNG), and Moderna Inc (MRNA), and the decrease in holdings of Schlumberger Limited (SLB), NVIDIA Corporation (NVDA), and Wells Fargo (WFC).

In conclusion, Hellman Jordan Management Co Inc's 13F filings provide valuable insight into their investment strategies, and analyzing their Q3 2022 vs. Q4 2022 holdings offers a glimpse into their decision-making process. It's fascinating to see how their holdings have shifted in response to market trends and changing opportunities, and we can only hope to gain further insights from their future filings.